HSCs are highly enriched within the VE-cadherin-expressing populations
Embryo age . | Organ . | Cells per organ(1×105)* . | HSCs per organ† . | HSC candidate phenotype . | Estimated HSC frequency . |
---|---|---|---|---|---|
11.5 | AGM | 1.4±0.12 | 1 | VE-cadherin+CD45+ | ∼1/70 |
VE-cadherin–CD45+ | – | ||||
12.5 | YS | 2.1±0.2 | 2 | VE-cadherin+CD45+ | ∼1/64 |
VE-cadherin–CD45+/– | – | ||||
PB | 28.7±2.9 | 3 | VE-cadherin+(CD45+) | ∼1/48 | |
VE-cadherin–(CD45+/–) | – | ||||
13.5 | FL | 63.6±2.5 | 260 | VE-cadherin+CD45+ | ∼1/127 |
VE-cadherin+CD45+ | ∼1/2,226 |
Embryo age . | Organ . | Cells per organ(1×105)* . | HSCs per organ† . | HSC candidate phenotype . | Estimated HSC frequency . |
---|---|---|---|---|---|
11.5 | AGM | 1.4±0.12 | 1 | VE-cadherin+CD45+ | ∼1/70 |
VE-cadherin–CD45+ | – | ||||
12.5 | YS | 2.1±0.2 | 2 | VE-cadherin+CD45+ | ∼1/64 |
VE-cadherin–CD45+/– | – | ||||
PB | 28.7±2.9 | 3 | VE-cadherin+(CD45+) | ∼1/48 | |
VE-cadherin–(CD45+/–) | – | ||||
13.5 | FL | 63.6±2.5 | 260 | VE-cadherin+CD45+ | ∼1/127 |
VE-cadherin+CD45+ | ∼1/2,226 |